Search research articles
Contact Us
Filters
Showing results (51-60 of 56) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 56 results.
Cancer Discovery
|
May 11, 2021
Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing
Ansam Sinjab, Guangchun Han, Warapen Treekitkarnmongkol, et al.
Nature Medicine
|
May 29, 2023
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
Yanshuo Chu, Enyu Dai, Yating Li, et al.
Nature
|
January 17, 2020
B cells and tertiary lymphoid structures promote immunotherapy response
Beth A Helmink, Sangeetha M Reddy, Jianjun Gao, et al.
Nature
|
June 15, 2022
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy
Christopher P Vellano, Michael G White, Miles C Andrews, et al.
Nature
|
January 10, 2023
Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy
Christopher P Vellano, Michael G White, Miles C Andrews, et al.
Nature Communications
|
November 25, 2025
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidence
Melinda Soeung, Xinmiao Yan, Ciro Zanca, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 56) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 56 results.
Cancer Discovery
|
May 11, 2021
Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing
Ansam Sinjab, Guangchun Han, Warapen Treekitkarnmongkol, et al.
Nature Medicine
|
May 29, 2023
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
Yanshuo Chu, Enyu Dai, Yating Li, et al.
Nature
|
January 17, 2020
B cells and tertiary lymphoid structures promote immunotherapy response
Beth A Helmink, Sangeetha M Reddy, Jianjun Gao, et al.
Nature
|
June 15, 2022
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy
Christopher P Vellano, Michael G White, Miles C Andrews, et al.
Nature
|
January 10, 2023
Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy
Christopher P Vellano, Michael G White, Miles C Andrews, et al.
Nature Communications
|
November 25, 2025
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidence
Melinda Soeung, Xinmiao Yan, Ciro Zanca, et al.
Page
of 6